AddLife AB (publ)

AddLife AB (publ)

ALIF-B · ST · Healthcare / Medical Instruments & Supplies

182.10SEK+0.40 (+0.22%)

Price History

Full chart

Market Stats

Previous Close181.70
Open181.80
Day Range179.50 – 182.50
52-Week Range128.86 – 206.26
Volume82.94K
Market Cap20.62B
P/E (TTM)34.60
Forward P/E0.00
EPS4.89
Dividend Yield0.89%
Beta1.55
50-Day Avg162.80
200-Day Avg153.72

About

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical services; and in the areas of microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics, as well as in the food industry. This segment also provides training programs for its customers. The Medtech segment provides medical device products for surgery, orthopaedics, critical care, endoscopy, wound care, healthcare IT, ophthalmology, home adaptation, and technical aids, as well as surgical procedures, welfare technology, and assistive devices for the elderly and disabled. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland, Austria, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Fredrik Dalborg
  • Employees2.36K
  • HeadquartersBrunkebergstorg 5, Stockholm, Sweden, 103 62, Sweden
  • Websitehttps://www.add.life

Leadership

  • Mr. Fredrik DalborgPresident & CEO · b. 1972
  • Ms. Christina RubenhagChief Financial Officer · b. 1970
  • Julie O'LearyInvestor Relations Manager
  • Timmy RosendalHead of Sustainability
  • Ms. Jamilah WassGroup Financial Controller
  • Johanna PrimGroup Financial Controller

Financials

Income Statement

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue906.50M983.50M1.72B1.56B1.94B2.33B2.48B3.48B5.27B7.99B9.08B9.69B10.29B10.44B
Growth (%)-+8.49%+75.15%-9.30%+24.06%+20.38%+6.36%+40.21%+51.56%+51.57%+13.66%+6.62%+6.21%+1.52%
Cost of Revenue553.30M608.50M1.11B1.01B1.27B1.49B1.59B2.28B3.45B5.14B5.66B6.09B6.43B6.46B
Gross Profit353.20M375.00M609.10M547.70M670.00M840.90M889.80M1.20B1.82B2.86B3.43B3.60B3.86B3.98B
Gross Margin38.96%38.13%35.36%35.06%34.57%36.04%35.86%34.44%34.48%35.74%37.73%37.16%37.52%38.09%
Operating Expense254.60M271.10M466.40M441.40M529.90M675.00M722.10M1.00B1.15B1.86B2.62B3.01B3.14B3.20B
Operating Income98.60M103.90M142.70M106.30M140.10M165.90M167.70M196.20M672.50M996.20M808.00M585.00M721.00M780.00M
Operating Margin10.88%10.56%8.28%6.80%7.23%7.11%6.76%5.64%12.75%12.46%8.89%6.04%7.01%7.47%
EBITDA130.50M128.10M130.30M150.30M206.70M254.40M264.80M428.00M951.00M1.46B1.45B1.53B1.52B1.80B
EBITDA Margin14.40%13.02%7.56%9.62%10.66%10.90%10.67%12.30%18.03%18.33%15.96%15.84%14.75%17.26%
Net Income73.80M78.00M102.00M77.80M111.80M120.30M129.30M140.60M517.80M719.00M480.00M190.00M252.00M560.00M
Net Income Margin8.14%7.93%5.92%4.98%5.77%5.16%5.21%4.04%9.82%9.00%5.28%1.96%2.45%5.36%
R&D-2.53M1.90M1.90M1.90M17.60M19.50M24.30M23.90M33.50M81.00M167.00M76.00M57.00M
R&D as % of Total Revenue-0.26%0.11%0.12%0.10%0.75%0.79%0.70%0.45%0.42%0.89%1.72%0.74%0.55%
Interest Expense1.30M900.00K8.70M6.60M2.80M9.30M7.20M12.40M17.80M59.00M126.00M288.00M319.00M212.00M
Interest Expense % of Total Revenue0.14%0.09%0.51%0.42%0.14%0.40%0.29%0.36%0.34%0.74%1.39%2.97%3.10%2.03%

Balance Sheet

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets608.90M613.20M643.30M1.28B1.58B1.89B2.67B3.27B4.15B10.60B13.06B12.74B13.05B12.71B
Total Liabilities315.60M341.60M380.00M930.50M859.80M1.14B1.74B1.80B2.26B6.30B8.09B7.79B7.75B7.26B
Total Equity292.30M270.80M263.00M346.60M716.90M748.00M930.70M1.47B1.88B4.29B4.97B4.96B5.31B5.44B
Cash111.40M76.80M82.50M11.60M14.70M11.00M60.60M99.10M216.00M345.30M376.00M272.00M331.00M813.00M
Total Debt28.80M32.10M28.10M486.20M166.90M532.70M848.90M896.30M805.80M4.10B5.59B5.29B5.07B4.77B
Net Debt-82.60M-44.70M-54.40M474.60M306.10M521.70M785.00M797.20M589.80M3.76B5.21B5.02B4.74B3.96B

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow118.60M91.60M120.40M117.70M132.90M208.00M177.50M400.40M950.10M1.01B909.00M773.00M1.09B1.39B
Investing Cash Flow-20.40M-12.30M-15.20M-272.10M-198.00M-337.80M-381.10M-407.00M-428.70M-2.98B-1.09B-317.00M-386.00M-497.00M
Financing Cash Flow-75.70M-116.10M-100.50M86.70M-55.20M125.30M248.60M42.20M-372.50M2.07B134.00M-554.00M-682.00M-305.00M
Capital Expenditure9.60M13.30M16.40M41.90M44.10M42.90M49.00M85.50M92.20M143.90M282.00M226.00M297.00M284.00M
Free Cash Flow109.00M78.30M104.00M75.80M88.80M165.10M128.50M314.90M857.90M866.30M627.00M547.00M798.00M1.11B
Dividends Paid92.50M96.60M80.00M294.90M276.80M36.60M53.20M62.10M56.20M183.00M243.00M146.00M61.00M91.00M
FCF to OCF91.91%85.48%86.38%64.40%66.82%79.38%72.39%78.65%90.30%85.76%68.98%70.76%72.88%79.60%
Dividend Paid to FCF84.86%123.37%76.92%389.05%311.71%22.17%41.40%19.72%6.55%21.12%38.76%26.69%7.64%8.21%

Earnings

Report DateMay 18, 2016Jul 15, 2016Oct 27, 2016Feb 16, 2017Apr 28, 2017Jul 17, 2017Oct 26, 2017Feb 13, 2018Apr 27, 2018Jul 13, 2018Nov 7, 2018Feb 12, 2019May 9, 2019Jul 12, 2019Nov 7, 2019Feb 6, 2020Apr 28, 2020Jul 17, 2020Oct 21, 2020Feb 3, 2021Apr 28, 2021Jul 15, 2021Oct 22, 2021Feb 4, 2022Apr 28, 2022Jul 15, 2022Oct 27, 2022Feb 2, 2023Apr 26, 2023Jul 14, 2023Oct 26, 2023Feb 2, 2024Apr 24, 2024Jul 15, 2024Oct 23, 2024Feb 5, 2025Apr 25, 2025Jul 15, 2025Oct 23, 2025Feb 4, 2026Apr 28, 2026Jul 16, 2026Oct 21, 2026
EPS Estimate0.100.030.500.360.340.430.280.61---------------1.681.460.900.470.480.490.510.21-0.180.510.580.380.650.901.320.991.081.121.900.91
EPS Actual0.950.240.720.480.300.300.220.420.260.340.240.430.340.270.230.430.481.061.121.942.011.461.131.451.840.620.980.501.430.270.20-0.340.520.600.190.760.980.830.661.151.041.06-
Surprise850.00%700.00%44.00%33.33%-11.76%-30.23%-21.43%-31.15%----------------13.69%26.03%-31.11%108.51%4.17%191.84%-47.06%-4.76%-88.89%1.96%3.45%-50.00%16.92%8.89%-37.12%-33.33%6.48%-7.14%-44.21%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap20.62B
Enterprise Value25.43B
Trailing P/E34.60
Forward P/E0.00
Price / Sales1.96
Price / Book3.65
EPS4.89
Book Value46.71
Revenue (TTM)10.53B
Gross Profit (TTM)4.05B
EBITDA1.44B
Profit Margin5.68%
Operating Margin8.67%
Return on Equity10.94%
Return on Assets4.18%
Shares Outstanding117.29M
Shares Float113.30M
Beta1.55
Dividend Yield0.89%
Dividend Rate1.50
Payout Ratio38.36%

Dividends

20261×
1.50May 7, 2026
20251×
0.75May 9, 2025
20241×
0.50May 10, 2024
20221×
2.00May 6, 2022
20211×
1.50May 6, 2021
20201×
0.50Nov 20, 2020
20191×
0.55May 10, 2019
20181×
0.52Jun 1, 2018
20171×
0.36May 30, 2017

Stock Splits

  • May 27, 20204:1